An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
Public ClinicalTrials.gov record NCT00746967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Center Extension Study To Evaluate The Safety, Toleration And Sustained Efficacy Of Oral Sildenafil Administered To Women Who Have Been Diagnosed With Female Sexual Arousal Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and toleration of oral sildenafil administered as required by women with Female Sexual Arousal Disorder (FSAD) who successfully complete one of the following Pfizer-sponsored, 12-week, double-blinded clinical trials: A1481082 or A1481123. Addition of this 52-week open-label extension will increase the total duration of sildenafil exposure to 64 weeks. Sustained efficacy will also be evaluated after 3 and 6 months of open-label therapy.
Study identification
- NCT ID
- NCT00746967
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 267 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Feb 2004 (Actual)
- Last update posted
- Feb 1, 2021
2003 – 2004
United States locations
- U.S. sites
- 82
- U.S. states
- 32
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Anchorage | Alaska | 99502 | — |
| Pfizer Investigational Site | Anchorage | Alaska | 99508 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85712 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85719 | — |
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Albany | California | 94706 | — |
| Pfizer Investigational Site | Berkeley | California | 94705 | — |
| Pfizer Investigational Site | Beverly Hills | California | 90210 | — |
| Pfizer Investigational Site | Beverly Hills | California | 90212 | — |
| Pfizer Investigational Site | Burbank | California | 91506 | — |
| Pfizer Investigational Site | Fair Oaks | California | 95628 | — |
| Pfizer Investigational Site | Hermosa Beach | California | 90254 | — |
| Pfizer Investigational Site | Oakland | California | 94612 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92108 | — |
| Pfizer Investigational Site | Santa Monica | California | 90404 | — |
| Pfizer Investigational Site | Torrance | California | 90505 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80012 | — |
| Pfizer Investigational Site | Hamden | Connecticut | 06518 | — |
| Pfizer Investigational Site | New London | Connecticut | 06320 | — |
| Pfizer Investigational Site | Waterbury | Connecticut | 06708 | — |
| Pfizer Investigational Site | Aventura | Florida | 33180 | — |
| Pfizer Investigational Site | Brooksville | Florida | 34614 | — |
| Pfizer Investigational Site | Jensen Beach | Florida | 34957 | — |
| Pfizer Investigational Site | Miami | Florida | 33186 | — |
| Pfizer Investigational Site | New Port Richey | Florida | 34652 | — |
| Pfizer Investigational Site | Palm Harbor | Florida | 34683 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Pfizer Investigational Site | Plantation | Florida | 33324 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33710 | — |
| Pfizer Investigational Site | Stuart | Florida | 34994 | — |
| Pfizer Investigational Site | Stuart | Florida | 34996 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33409 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Marietta | Georgia | 30060 | — |
| Pfizer Investigational Site | Savannah | Georgia | 31405 | — |
| Pfizer Investigational Site | Boise | Idaho | 83702 | — |
| Pfizer Investigational Site | Boise | Idaho | 83712 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47714 | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | 46825 | — |
| Pfizer Investigational Site | Newburgh | Indiana | 47630 | — |
| Pfizer Investigational Site | Leawood | Kansas | 66211 | — |
| Pfizer Investigational Site | Crestview Hills | Kentucky | 41017 | — |
| Pfizer Investigational Site | Florence | Kentucky | 41042 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70002 | — |
| Pfizer Investigational Site | Greenbelt | Maryland | 20770 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Pfizer Investigational Site | Southfield | Michigan | 48034 | — |
| Pfizer Investigational Site | Creve Coeur | Missouri | 63141 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89014 | — |
| Pfizer Investigational Site | North Las Vegas | Nevada | 89030 | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | 08903 | — |
| Pfizer Investigational Site | New York | New York | 10021 | — |
| Pfizer Investigational Site | Poughkeepsie | New York | 12601 | — |
| Pfizer Investigational Site | Rochester | New York | 14609 | — |
| Pfizer Investigational Site | White Plains | New York | 10603 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Beachwood | Ohio | 44122-5402 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0559 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19106 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19148 | — |
| Pfizer Investigational Site | Reading | Pennsylvania | 19606 | — |
| Pfizer Investigational Site | Reading | Pennsylvania | 19607-1649 | — |
| Pfizer Investigational Site | Temple | Pennsylvania | 19560 | — |
| Pfizer Investigational Site | West Reading | Pennsylvania | 19611-1499 | — |
| Pfizer Investigational Site | Providence | Rhode Island | 02904 | — |
| Pfizer Investigational Site | Anderson | South Carolina | 29621 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Austin | Texas | 78758 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Houston | Texas | 77024 | — |
| Pfizer Investigational Site | Sandy City | Utah | 84070 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | 22903 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Renton | Washington | 98055 | — |
| Pfizer Investigational Site | Seattle | Washington | 98105 | — |
| Pfizer Investigational Site | Seattle | Washington | 98115 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53209 | — |
| Pfizer Investigational Site | Cheyenne | Wyoming | 82001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00746967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2021 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00746967 live on ClinicalTrials.gov.